 | |
- close
- close
|
Business Standard
Oct 29
Comment
Biocon has managed to heal the wound fast. Indias largest biotechnology company, which straddles high-end drug research to generics, bet the wrong way on how the rupee will move against the dollar and paid a big price last year.
Business Standard
Oct 24
Comment
Hardly five months after it entered into an exclusive product development and supply pact with global generic drug major Mylan, the countrys biggest biotech firm, Biocon, has started receiving milestone payments from its US-based partner.
The Economic Times
Oct 23
Comment
India Infoline has advised traders to buy Biocon for target of Rs 293.
Business Standard
Oct 22
Comment
Bangalore-based biotech major Biocon has more than tripled its net profit to Rs 76 crore in the July-September quarter compared with Rs 25 crore in the same period last year. Total revenue during the period rose 31 per cent to Rs 581 crore,...
The Economic Times
Oct 22
Comment
Biocon posted a net profit of $13.85 million (Rs.62.36 crore) in the quarter end.
Business Standard
Oct 1
Comment
Gulf Oil Corpoation hit the 5 per cent circuit to close at Rs 83 on entering into an agreement with Biocon to sell its Active Pharmaceuticals Ingredients undertaking, for an undisclosed amount.
The Economic Times
Oct 1
Comment
The Indian rupee was at 47.87 against the dollar from previous close of 48.10.
The Economic Times
Sep 30
Comment
Biocon Ltd, India's top listed biotechnology firm, said on Wednesday the firm would acquire the bulk pharmaceutical business undertaking of IDL Specialty Chemicals Ltd, located near Hyderabad.
The Economic Times
Sep 28
Comment
Nooyi is among 4 Indians making it to the list including Britannia Industries head Vinita Bali and Biocon CMD Kiran Mazumdar-Shaw. Savvy girls in 20s new scions
The Economic Times
Sep 24
Comment
Biocon Limited, India's leading biotechnology major, has been included in the presitigious `Best Under A Billion' listing by Forbes magazine.
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSISBiocon is India's leading biotechnology enterprise. Established in 1978, the company today is an integrated biotechnology enterprise focused on the development of biopharmaceuticals. The company serves partners and customers in over 50 countries. Within the biotechnology space, the company ranks first in Asia in terms of revenues and market capitalisation and sixteenth globally.
The company is headed by Kiran Mazumdar-Shaw. Biocon went for an IPO in 2004. Biocon became only the second Indian company to cross a market capitalisation of one billion U.S. $ on the first day of listing. Mazumdar-Shaw and her husband John Shaw own over 60% of the company's stock.
| ||||||
|
|
